SABCS: Trastuzumab Dosing During Chemo Vindicated (CME/CE)
SAN ANTONIO (MedPage Today) Delaying trastuzumab (Herceptin) until after chemotherapy may impair outcomes for women with breast cancer, researchers found.
source : www.medpagetoday.com
How DUMB are YOU?!
Do your friends think you are stupid? Take the challenge and prove them wrong!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Home Income Profit System
You can make money working from the comfort of your own home!
CreditReport.com
Get your credit report and score in just seconds!
Take the IQ Challenge!
Are you as stupid as your friends think? Prove them wrong with this quick IQ Challenge game!
Do your friends think you are stupid? Take the challenge and prove them wrong!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Home Income Profit System
You can make money working from the comfort of your own home!
CreditReport.com
Get your credit report and score in just seconds!
Take the IQ Challenge!
Are you as stupid as your friends think? Prove them wrong with this quick IQ Challenge game!
Related News:
- SGO: New Option for Recurrent Ovarian Cancer? (CME/CE)
- Pregnancy Linked to Critical H1N1 Illness (CME/CE)
- Greater Infection Risk with Staples in Hip Surgery (CME/CE)
- ACC: Radial Artery Matches Saphenous Vein for CABG (CME/CE)
- SIR: Combo of Embolization and Bevacizumab Safe (CME/CE)
- SIR: Cryotherapy Effective in Soft Tissue (CME/CE)
- SGO: HPV Vaccine Stops Recurrence After Surgery (CME/CE)
- SGO: No Lung CA Risk Seen with Estrogen (CME/CE)
- SSRI, Naltrexone, Talk Therapy Keep Depressed Alcoholics Dry (CME/CE)
- Gaps Remain in Cancer Palliative Care (CME/CE)
Details :
Submited at Sunday, December 13th, 2009 at 7:00 pm on Cardiology by sofia
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...